Theranostics News and Research

RSS
Scientists create first 3-D living tissue model of glioma

Scientists create first 3-D living tissue model of glioma

NIH awards $3.2M for development of highly efficient system of generating nucleic acid molecules

NIH awards $3.2M for development of highly efficient system of generating nucleic acid molecules

Cambridge Theranostics' liquidators set deadline for offers

Cambridge Theranostics' liquidators set deadline for offers

Women with inflammatory breast cancer now have a chance of treatment

Women with inflammatory breast cancer now have a chance of treatment

Astronomers to develop potential new cancer radiation treatment

Astronomers to develop potential new cancer radiation treatment

QIAGEN to acquire minority stake in Alacris Theranostics

QIAGEN to acquire minority stake in Alacris Theranostics

Techulon signs exclusive license with Virginia Tech to market new theranostic transfection reagent

Techulon signs exclusive license with Virginia Tech to market new theranostic transfection reagent

Techulon signs license with Virginia Tech Intellectual Properties to market DNA delivery platform

Techulon signs license with Virginia Tech Intellectual Properties to market DNA delivery platform

Spectral commences pivotal Toraymyxin trial for severe sepsis

Spectral commences pivotal Toraymyxin trial for severe sepsis

Researchers to test nanoparticle-based theranostics for pancreatic cancer treatment

Researchers to test nanoparticle-based theranostics for pancreatic cancer treatment

Mount Sinai receives contract to develop nanotechnology tools for diagnosing diseases

Mount Sinai receives contract to develop nanotechnology tools for diagnosing diseases

MIRACLE project to develop lab-on-chip system for diagnosing cancer

MIRACLE project to develop lab-on-chip system for diagnosing cancer

JNM supplement examines advances in cardiovascular molecular imaging

JNM supplement examines advances in cardiovascular molecular imaging

Researchers explore use of nanomedicine techniques for treatment of diseases in children

Researchers explore use of nanomedicine techniques for treatment of diseases in children

FDA grants approval to Spectral Diagnostics for pivotal trial of Toraymyxin

FDA grants approval to Spectral Diagnostics for pivotal trial of Toraymyxin

Scientists discover new technique to destroy individual diseased cells

Scientists discover new technique to destroy individual diseased cells

Clarient announces acquisition of Applied Genomics

Clarient announces acquisition of Applied Genomics

Nanoparticle could allow diagnosis and treatment in one visit

Nanoparticle could allow diagnosis and treatment in one visit

GlaxoSmithKline and bioMerieux to develop predictive test for breast cancer treatments

GlaxoSmithKline and bioMerieux to develop predictive test for breast cancer treatments

Future for magnetic nanoparticles appears even brighter

Future for magnetic nanoparticles appears even brighter